Basic Information
NovAliX SAS is a CRO focused on drug discovery, possessing one of the most comprehensive biophysical platforms in the world. It concentrates on developing enabling chemical and biophysical technologies to support the pharmaceutical industry’s outsourcing needs from discovery to manufacturing. With expertise in X-ray protein crystallography, supramolecular mass spectrometry, and organic chemistry, NovAliX provides comprehensive integrated services for small molecule drug discovery. Utilizing advanced NMR technology, NovAliX offers detailed characterization of biologics, complete API analysis, and polymorphism studies to support drug development and manufacturing teams.
NovAliX SAS
Strasbourg,GreatEast,France
51~100 people
January 01, 2002
info@novalix.com

